174 related articles for article (PubMed ID: 10358028)
1. 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor.
Yang W; Freedman LP
J Biol Chem; 1999 Jun; 274(24):16838-45. PubMed ID: 10358028
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
3. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
4. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
5. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
6. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
7. Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiation.
Oda Y; Sihlbom C; Chalkley RJ; Huang L; Rachez C; Chang CP; Burlingame AL; Freedman LP; Bikle DD
Mol Endocrinol; 2003 Nov; 17(11):2329-39. PubMed ID: 12893881
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
10. Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor.
Peleg S; Sastry M; Collins ED; Bishop JE; Norman AW
J Biol Chem; 1995 May; 270(18):10551-8. PubMed ID: 7737990
[TBL] [Abstract][Full Text] [Related]
11. Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription.
Lemon BD; Fondell JD; Freedman LP
Mol Cell Biol; 1997 Apr; 17(4):1923-37. PubMed ID: 9121440
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
Barletta F; Freedman LP; Christakos S
Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
Miura D; Manabe K; Ozono K; Saito M; Gao Q; Norman AW; Ishizuka S
J Biol Chem; 1999 Jun; 274(23):16392-9. PubMed ID: 10347199
[TBL] [Abstract][Full Text] [Related]
15. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.
Bury Y; Herdick M; Uskokovic MR; Carlberg C
J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583
[TBL] [Abstract][Full Text] [Related]
16. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.
Liu YY; Collins ED; Norman AW; Peleg S
J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
18. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction.
Kraichely DM; Collins JJ; DeLisle RK; MacDonald PN
J Biol Chem; 1999 May; 274(20):14352-8. PubMed ID: 10318858
[TBL] [Abstract][Full Text] [Related]
19. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
20. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
